Yves Legrand

Title: Yves Legrand: Innovator in Gene Therapy

Introduction

Yves Legrand is a prominent inventor based in Paris, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of tumors. With a total of 2 patents, his work focuses on innovative methods to combat cancer through advanced therapeutic techniques.

Latest Patents

One of Yves Legrand's latest patents is titled "Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors." This invention relates to gene therapy aimed at treating tumors by introducing a gene encoding an anti-angiogenic factor into tumor cells using a defective adenovirus vector. The method has shown promising results in inhibiting tumor growth and metastasis, as well as reducing neovascularization at the injection site. Another notable patent involves "Oligopeptides with specific inhibiting properties of collagen," which further showcases his innovative approach to cancer treatment.

Career Highlights

Throughout his career, Yves Legrand has worked with various companies, including Gencell Sas and Choay, S.A. His experience in these organizations has allowed him to develop and refine his expertise in gene therapy and related fields.

Collaborations

Yves has collaborated with notable professionals in his field, including Hong Li and He Lu. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yves Legrand is a distinguished inventor whose work in gene therapy has the potential to revolutionize cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.